Tuberculosis drugs and drug targets

Infectious Disorders - Drug Targets

Volumn 7, Issue 2, 2007, Pages 71-72

  Goldman, Robert C ^a   Laughon, Barbara E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING); ISONIAZID; KANAMYCIN; OXIDOREDUCTASE; PEPTIDOGLYCAN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFUR; TUBERCULOSTATIC AGENT;

ANTIMICROBIAL ACTIVITY; BACTERIAL CELL WALL; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CRYSTALLOGRAPHY; CYTOTOXICITY; DRUG RESEARCH; DRUG TARGETING; EDITORIAL; EPIDEMIC; GOVERNMENT; HEALTH CARE NEED; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SUPERINFECTION; TUBERCULOSIS;

EID: 34547118563     PISSN: 18715265     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152607781001835     Document Type: Editorial

References (0)